Background: Primary Sjögren’s syndrome (PSS) is associated with various histological patterns of interstitial lung disease. Although chest images and lung function studies showed that lung involvement predominantly occurs in small airways, pathological findings were not consistent with the results of high-resolution CT (HRCT) and lung function tests. Objectives: To investigate the pathological characteristics of PSS-associated interstitial lung disease (PSS-ILD) and their relationship with HRCT lung function tests. Methods: Fourteen patients diagnosed as PSS who underwent surgical lung biopsy in Peking Union Medical College Hospital from October 2000 to October 2006 were reviewed. Histopathologic findings, radiologic findings and lung function tests were analyzed. Results: The study included 13 women. The median age was 46 years. Most patients presented with dyspnea and cough. CT scans revealed bilateral ground-glass, consolidative, reticular and nodular opacities and cyst lesions. The histological patterns included nonspecific interstitial pneumonia (NSIP) cellular pattern associated with organizing pneumonia (OP), NSIP mixed pattern associated with OP, noncaseating granulomas, chronic bronchiolitis, follicular bronchiolitis, constrictive bronchiolitis, lymphocytic interstitial pneumonia associated with follicular bronchiolitis, NSIP mixed pattern associated with follicular bronchiolitis, NSIP mixed pattern coexisting with chronic bronchiolitis, OP associated with chronic bronchiolitis, and noncaseating granulomas coexisting with OP. Treatment included prednisone and cyclophosphamide. During the follow-up period (median 38 months), most patients improved or remained stable. The patient with constrictive bronchiolitis died from progression of primary disease. Conclusions: The histopathologic patterns of PSS-ILD included lung interstitial involvement and small airway involvement or both. Corticosteroid therapy combined with cyclophosphamide was administered with a favorable response in the majority of patients.

1.
Bloch KJ, Buchanan WW, Wohl MJ, Bunim JJ: Sjögren’s syndrome: a clinical, pathological, and serological study of sixty-two cases. Medicine 1965;44:187–231.
2.
Kassan SS, Moutsopoulos HM: Clinical manifestations and early diagnosis of Sjögren’s syndrome. Arch Intern Med 2004;164:1275–1284.
3.
Gardiner P, Ward C, Allison A, Ashcroft T, Simpson W, Walters H, Kelly C: Pleuropulmonary abnormalities in primary Sjögren’s syndrome. Clin Rheumatol 1993;205:831–837.
4.
Fox RI, Michelson P: Approaches to the treatment of Sjögren’s syndrome. J Rheumatol Suppl 2000;61:15–21.
5.
Strimlan VC, Rosenow EC 3rd, Divertie MB, Harrison EG Jr: Pulmonary manifestations of Sjögren’s syndrome. Chest 1976;70:354–361.
6.
Oxholm P, Asmussen K: Primary Sjögren’s syndrome: the challenge for classification of disease manifestations. J Intern Med 1996;239:467–474.
7.
Constantopoulos SH, Papadimitriou CS, Moutsopoulos HM: Respiratory manifestations in primary Sjögren’s syndrome. A clinical, functional, and histologic study. Chest 1985;88:226–229.
8.
Oxholm P, Bundgaard A, Birk Madsen E, Manthorpe R, Vejlo Rasmussen F: Pulmonary function in patients with primary Sjögren’s syndrome. Rheumatol Int 1982;2:179–181.
9.
Newball HH, Brahim SA: Chronic obstructive airway disease in patients with Sjögren’s syndrome. Am Rev Respir Dis 1977;1152:295–304.
10.
Deheinzelin D, Capelozzi VL, Kairalla RA, Barbas Filho JV, Saldiva PH, de Carvalho CR: Interstitial lung disease in primary Sjögren’s syndrome: clinical-pathological evaluation and response to treatment. Am J Respir Crit Care Med 1996;154:794–799.
11.
Parambil JG, Myers JL, Lindell RM, Matteson EL, Ryu JH: Interstitial lung disease in primary Sjögren syndrome. Chest 2006;1305:1489–1495.
12.
Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH; European Study Group on Classification Criteria for Sjögren’s Syndrome: Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;616:554–558.
13.
American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2002;165:277–304.
14.
Bradley B, Branley HM, et al; BTS Interstitial Lung Disease Guideline Group, British Thoracic Society Standards of Care Committee; in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society: Interstitial lung disease guideline. Thorax 2008;63:v1–v58.
15.
Salaffi F, Manganelli P, Carotti M, Baldelli S, Blasetti P, Subiaco S, Binci MC, Bichi Secchi E, Amici F, Cervini C: A longitudinal study of pulmonary involvement in primary Sjögren’s syndrome: relationship between alveolitis and subsequent lung changes on high-resolution computed tomography. Br J Rheumatol 1998;37:263–269.
16.
Nakamura N, Yamada G, Itoh T, Suzuki A, Morita-Ichimura S, Teramoto S, Shijubo N, Koba H, Satoh M, Abe S: Pulmonary MALT lymphoma with amyloid production in a patient with primary Sjögren’s syndrome. Intern Med 2002;414:309–311.
17.
Kurumagawa T, Kobayashi H, Motoyoshi K: Potential involvement of subclinical Sjögren’s syndrome in various lung diseases. Respirology 2005;10:86–91.
18.
Fairfax AJ, Haslam PL, Pavia D, Sheahan NF, Bateman JR, Agnew JE, Clarke SW, Turner-Warwick M: Pulmonary disorders associated with Sjögren’s syndrome. Q J Med 1981;50:279–295.
19.
Vitali C, Tavoni A, Viegi G, Begliomini E, Agnesi A, Bombardieri S: Lung involvement in Sjögren’s syndrome: a comparison between patients with primary and with secondary syndrome. Ann Rheum Dis 1985;44:455–461.
20.
Constantopoulos SH, Papadimitriou CS, Moutsopoulos HM: Respiratory manifestations in primary Sjögren’s syndrome. A clinical, functional, and histologic study. Chest 1985;88:226–229.
21.
Papathanasiou MP, Constantopoulos SH, Tsampoulas C, Drosos AA, Moutsopoulos HM: Reappraisal of respiratory abnormalities in primary and secondary Sjögren’s syndrome. Chest 1986;90:370–374.
22.
Ito I, Nagai S, Kitaichi M, Nicholson AG, Johkoh T, Noma S, Kim DS, Handa T, Izumi T, Mishima M: Pulmonary manifestations of primary Sjögren’s syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med 2005;171:632–638.
23.
Alkhayer M, McCann BG, Harrison BD: Lymphocytic interstitial pneumonitis in association with Sjögren’s syndrome. Br J Dis Chest 1988;82:305–309.
24.
Kamholz S, Sher A, Barland P, Rosen N, Rakoff S, Becker N: Sjögren’s syndrome: severe upper airways obstruction due to primary malignant tracheal lymphoma developing during successful treatment of lymphocytic interstitial pneumonitis. J Rheumatol 1987;14:588–594.
25.
Parker JS, Shellito J, Pei LA, Mason CM: Lymphocytic interstitial pneumonitis presenting as recurrent pneumothoraces. Chest 1991;100:1733–1735.
26.
Usui Y, Kimula Y, Miura H, Kodaira Y, Takayama S, Nakayama M, Kataoka N: A case of bronchiolitis obliterans organizing pneumonia associated with primary Sjögren’s syndrome who died of superimposed diffuse alveolar damage. Respiration 1992;59:122–124.
27.
Matteson EL, Ike RW: Bronchiolitis obliterans organizing pneumonia and Sjögren’s syndrome. J Rheumatol 1990;17:676–679.
28.
Hayashi R, Yamashita N, Sugiyama E, Maruyama M, Matsui S, Yoshida Y, Arai N, Kobayashi M: A case of primary Sjögren’s syndrome with interstitial pneumonia showing bronchiolitis obliterans organizing pneumonia pattern and lymphofollicular formation (abstract). Nihon Kokyuki Gakkai Zasshi 2000;38:880–884.
29.
Kadota J, Kusano S, Kawakami K, Morikawa T, Kohno S: Usual interstitial pneumonia associated with primary Sjögren’s syndrome. Chest 1995;108:1756–1758.
30.
Yamadori I, Fujita J, Bandoh S, Tokuda M, Tanimoto Y, Kataoka M, Yamasaki Y, Yoshinouchi T, Ohtsuki Y, Ishida T: Nonspecific interstitial pneumonia as pulmonary involvement of primary Sjögren’s syndrome. Rheumatol Int 2002;22:89–92.
31.
Moisiuc FV, Colt HG: Horacoscopy: origins revisited. Respiration 2007;74:344–355.
32.
Andersen HA: Transbronchoscopic lung biopsy for diffuse pulmonary diseases: results in 939 patients. Chest 1978;73:734–736.
33.
Wall CP, Gaensler EA, Carrington CB, Hayes JA: Comparison of transbronchial and open biopsies in chronic infiltrative lung diseases. Am Rev Respir Dis 1981;123:280–285.
34.
Wilson RK, Fechner RE, Greenberg SD, et al: Clinical implications of a ‘nonspecific’ transbronchial biopsy. Am J Med 1978;65:252–256.
35.
King TE Jr, Tooze JA, Schwarz MI, et al: Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 2001;164:1171–1181.
36.
Taouli B, Brauner MW, Mourey I, Lemouchi D, Grenier PA: Thin-section chest CT findings of primary Sjögren’s syndrome: correlation with pulmonary function. Eur Radiol 2002;12:1504–1511.
37.
Lohrmann C, Uhl M, Warnatz K, Ghanem N, Kotter E, Schaefer O, Langer M: High-resolution CT imaging of the lung for patients with primary Sjögren’s syndrome. Eur J Radiol 2004;52:137–143.
38.
Miyata M, Takase Y, Kobayashi H, Kokubun M, Yoshimura A, Katsuura Y, Nishimaki T, Kasukawa R: Primary Sjögren’s syndrome complicated by sarcoidosis. Intern Med 1998;37:174–178.
39.
Hiraoka A, Kojima N, Yamauchi Y, Ninomiya T, Masumoto T, Michitaka K, Horiike N, Onji M: An autopsy case of primary biliary cirrhosis with severe interstitial pneumonia. Intern Med 2001;40:1104–1108.
40.
Shulimzon T, Rozenman J, Perelman M, Bardan E, Ben-Dov I: Necrotizing granulomata in the lung preceding colonic involvement in 2 patients with Crohn’s disease. Respiration 2007;74:698–702.
41.
Papiris SA, Maniati M, Constantopoulos SH, Roussos C, Moutsopoulos HM, Skopouli FN: Lung involvement in primary Sjögren’s syndrome is mainly related to the small airway disease. Ann Rheum Dis 1999;58:61–64.
42.
Franquet T, Giménez A, Monill JM, Díaz C, Geli C: Primary Sjögren’s syndrome and associated lung disease: CT findings in 50 patients. AJR Am J Roentgenol 1997;169:655–658.
43.
Matsuyama N, Ashizawa K, Okimoto T, Kadota J, Amano H, Hayashi K: Pulmonary lesions associated with Sjögren’s syndrome: radiographic and CT findings. Br J Radiol 2003;76:880–884.
44.
Oymak FS, Demirba HM, Mavili E, Akgun H, Gulmez I, Demir R, Ozesmi M: Bronchiolitis obliterans organizing pneumonia. Clinical and roentgenological features in 26 cases. Respiration 2005;72:254–262.
45.
Fox RI: Sjögren’s syndrome. Lancet 2005;366:321–331.
46.
Manoussakis MN, Moutsopoulos HM: Sjögren’s syndrome: current concepts. Adv Intern Med 2001;47:191–217.
47.
Schnabel A, Reuter M, Gross WL: Intravenous pulse cyclophosphamide in the treatment of interstitial lung disease due to collagen vascular diseases. Arthritis Rheum 1998;4:1215–1220.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.